Abstract
Background
The efficacy of endovascular treatment (EVT) for intracranial atherosclerotic disease (ICAD) remains unclear. This study compared procedural and clinical outcomes of EVT for ICAD-related and cardiogenic embolism (CE)-related large vessel occlusion (LVO) using data from the Kanagawa Intravenous and Endovascular Treatment of Acute Ischemic Stroke registry, a prospective, multicenter observational study.
Methods
Of 3187 EVTs from 2018 to 2021, 2047 anterior circulation occlusions included 305 ICAD and 1742 CE cases. The primary endpoint was favorable functional outcome (mRS 0–2) at 90 days; secondary endpoints included recanalization rates, symptomatic intracranial hemorrhage, and puncture-to-recanalization time.
Results
ICAD-LVO patients were younger, had lower NIHSS scores, and showed a lower proportion of recanalization (74% vs. 91%, p < 0.0001) and longer procedural times (66 vs. 43 min, p < 0.0001) than CE patients. Symptomatic hemorrhage was also more frequent (8.5% vs. 5.2%, p = 0.0267). Despite these differences, favorable outcomes were comparable (41% vs. 38%, p = 0.3157). Onset-to-recanalization time was significantly associated with outcome in CE (aOR: 0.99, 95% CI: 0.99–1.000, p = 0.0147) but not in ICAD. DWI-ASPECTS strongly predicted favorable outcome in both groups (ICAD: aOR: 1.26, 95% CI: 1.085–1.46, p = 0.0024; CE: aOR: 1.30, 95% CI: 1.23–1.38, p < 0.0001).
Conclusions
EVT for ICAD-LVO was associated with a lower proportion of recanalization, longer procedure times and poorer procedural outcomes but similar 90-day functional outcomes compared with CE-LVO. In ICAD, DWI-ASPECTS was a key prognostic factor, while onset-to-recanalization time had limited impact, highlighting distinct pathophysiological mechanisms.
Registration
URL: https://www.clinicaltrials.gov; Unique identifier: NCT05213533
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
